Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-18 Sale | 2025-12-19 3:43 pm | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 5,121 | $67.15 | $343,889 | 8,762 (Direct) | View |
| 2025-09-24 Sale | 2025-09-26 3:53 pm | Monopar Therapeutics | MNPR | Tactic Pharma LLC Robinson Chandler Brown Michael J O'Halloran Thomas V. Mazar Andrew Paul 10% Owner | 550,229 | $63.61 | $34,999,957 | 272,026 (Direct) | View |
| 2025-07-14 Sale | 2025-07-16 9:06 pm | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 8,904 | $40 | $356,171 | 11,486 (Direct) | View |
| 2025-07-14 Sale | 2025-07-16 9:03 pm | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 16,800 | $40 | $672,020 | 15,053 (Indirect Direct) | View |
| 2025-07-14 Sale | 2025-07-16 9:02 pm | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 16,800 | $40 | $672,020 | 895,727 (Indirect Direct) | View |
| 2025-04-02 Sale | 2025-04-04 7:27 pm | Monopar Therapeutics | MNPR | Tactic Pharma LLC Robinson Chandler Brown Michael J O'Halloran Thomas V. Mazar Andrew Paul 10% Owner | 33,334 | $35 | $1,166,690 | 822,255 (Direct) | View |
| 2024-10-28 Purchase | 2024-10-30 4:17 pm | Monopar Therapeutics | MNPR | Radhakrishnan Karthik Chief Financial Officer | 1,550 | $16.25 | $25,188 | 1,550 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-16 Other | 2025-12-17 3:42 pm | N/A N/A | Monopar Therapeutics | MNPR | Hendricks Diane 10% Owner | 43,499 | $0 | 704,829 (Indirect) | View |
| 2025-12-16 Other | 2025-12-17 3:41 pm | N/A N/A | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 7,710 | $0 | 21,593 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:50 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 22,888 | $0 | 61,562 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:50 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 2,924 | $0 | 2,924 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:49 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 2,924 | $0 | 2,924 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:48 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Anderson Raymond Director | 2,924 | $0 | 2,924 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:48 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Talukdar Lavina Director | 2,924 | $0 | 2,924 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:47 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 2,924 | $0 | 2,924 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:47 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Vu Quan Anh Chief Financial Officer | 16,961 | $0 | 16,961 (Direct) | View |
| 2025-12-02 Option Award | 2025-12-08 4:46 pm | N/A 2035-12-02 | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 65,886 | $0 | 138,485 (Direct) | View |
| 2025-09-30 Tax Withholding | 2025-10-02 3:04 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,896 | $81.67 | 86,963 (Direct) | View |
| 2025-09-30 Exercise | 2025-10-02 3:04 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 4,327 | $0 | 86,963 (Direct) | View |
| 2025-09-30 Tax Withholding | 2025-10-02 3:04 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 2,646 | $81.67 | 424,177 (Direct) | View |
| 2025-09-30 Exercise | 2025-10-02 3:04 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 8,726 | $0 | 424,177 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-16 9:06 pm | N/A 2026-04-04 | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 8,904 | $0 | 11,486 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-16 9:06 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 8,904 | $0.005 | 11,486 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-16 9:03 pm | N/A 2026-04-04 | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 16,800 | $0 | 15,053 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-16 9:03 pm | N/A N/A | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 16,800 | $0.005 | 15,053 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-16 9:02 pm | N/A 2027-02-20 | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 16,800 | $0 | 895,727 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-16 9:02 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 16,800 | $0.005 | 895,727 (Direct) | View |
| 2025-06-30 Tax Withholding | 2025-07-02 4:25 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 5,865 | $35.78 | 977,052 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:25 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 13,344 | $0 | 977,052 (Direct) | View |
| 2025-06-30 Tax Withholding | 2025-07-02 4:24 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 2,990 | $35.78 | 88,859 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:24 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 6,863 | $0 | 88,859 (Direct) | View |
| 2025-03-31 Tax Withholding | 2025-04-02 9:08 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 744 | $36.41 | 91,849 (Direct) | View |
| 2024-03-31 Exercise | 2025-04-02 9:08 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 3,582 | $0 | 91,849 (Direct) | View |
| 2025-03-31 Tax Withholding | 2025-04-02 9:07 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 1,204 | $36.41 | 1,016,251 (Direct) | View |
| 2025-03-31 Exercise | 2025-04-02 9:07 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 4,106 | $0 | 1,016,251 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-07 9:24 pm | N/A 2035-03-04 | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 165,658 | $0 | 1,207,991 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-07 9:24 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 1,759 | $31.7 | 1,207,991 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-07 9:24 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 6,002 | $0 | 1,207,991 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-07 9:09 pm | N/A 2035-03-04 | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 84,026 | $0 | 95,100 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-07 8:14 pm | N/A 2035-03-04 | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 11,365 | $0 | 11,365 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-07 7:58 pm | N/A 2035-03-04 | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 11,365 | $0 | 11,365 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-07 7:55 pm | N/A 2035-03-04 | Monopar Therapeutics | MNPR | Anderson Raymond Director | 11,365 | $0 | 11,365 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-07 7:51 pm | N/A 2035-03-04 | Monopar Therapeutics | MNPR | Talukdar Lavina Director | 5,683 | $0 | 5,683 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-07 7:48 pm | N/A 2035-03-04 | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Director | 11,365 | $0 | 11,365 (Direct) | View |
Ownership | 2025-03-06 7:07 pm | N/A N/A | Monopar Therapeutics | MNPR | Talukdar Lavina Director | 0 | $0 | 14,001 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:06 pm | N/A 2035-03-02 | Monopar Therapeutics | MNPR | Vu Quan Anh Chief Financial Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-01-01 Option Award | 2025-01-02 6:16 pm | N/A 2034-12-31 | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 2,000 | $0 | 2,000 (Direct) | View |
| 2024-12-31 Tax Withholding | 2025-01-02 6:15 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 721 | $22 | 52,012 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-02 6:15 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,790 | $0 | 52,012 (Direct) | View |
| 2024-12-31 Tax Withholding | 2025-01-02 6:14 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 2,209 | $22 | 939,316 (Direct) | View |
| 2024-12-31 Exercise | 2025-01-02 6:14 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 4,895 | $0 | 939,316 (Direct) | View |
| 2024-12-09 Other | 2024-12-17 4:57 pm | N/A N/A | Monopar Therapeutics | MNPR | TacticGem LLC 10% Owner | 1,433,334 | $0 | 1,433,334 (Direct) | View |
| 2024-09-30 Exercise | 2024-10-02 7:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 4,895 | $0 | 941,525 (Direct) | View |
| 2024-09-30 Tax Withholding | 2024-10-02 7:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 1,918 | $6.74 | 941,525 (Direct) | View |
| 2024-09-30 Exercise | 2024-10-02 7:44 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,791 | $0 | 52,733 (Direct) | View |
| 2024-09-30 Tax Withholding | 2024-10-02 7:44 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 535 | $6.74 | 52,733 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 6:22 pm | N/A 2034-06-30 | Monopar Therapeutics | MNPR | Radhakrishnan Karthik Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |